Transforming growth factor-B: Master regulator of the respiratory system in health and disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 54, Issue 5, 2016, Pages 647-655

  Aschner, Yael ^a   Downey, Gregory P ^a,b,c,d  

^a Division of Pulmonary Sciences and Critical Care Medicine   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d DEPARTMENT OF MEDICINE   (United States)

Author keywords

Asthma; COPD; Fibroblast; Pulmonary arterial hypertension; Pulmonary fibrosis

Indexed keywords

BLOCKING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ASTHMA; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXTRACELLULAR MATRIX; GENE TARGETING; HEALTH STATUS; HOMEOSTASIS; HUMAN; IMMUNITY; LUNG DEVELOPMENT; LUNG FIBROSIS; NONHUMAN; PNEUMONIA; PULMONARY HYPERTENSION; RESPIRATORY FUNCTION; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; HEALTH; METABOLISM; PATHOLOGY; RESPIRATORY TRACT DISEASES;

ANIMALS; HEALTH; HOMEOSTASIS; HUMANS; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84988948694     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2015-0391TR     Document Type: Review

References (95)

1. MassaguéJ. TGFb signalling in context. Nat Rev Mol Cell Biol 2012;13: 616-630
2. Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J 2004; 18: 816-827
3. Morty RE, Königshoff M, Eickelberg O. Transforming growth factor-b signaling across ages: from distorted lung development to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6: 607-613
4. MassaguéJ, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005;19:2783-2810
5. Horiguchi M, Ota M, Rifkin DB. Matrix control of transforming growth factor-b function. J Biochem 2012;152:321-329
6. Tatler AL, Jenkins G. TGF-β activation and lung fibrosis. Proc Am Thorac Soc 2012;9:130-136
7. Saharinen J, Taipale J, Keski-Oja J. Association of the small latent transforming growth factor-b with an eight cysteine repeat of its binding protein LTBP-1. EMBO J 1996;15:245-253
8. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997;91:439-442
9. Verrecchia F, Mauviel A. Transforming growth factor-b signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 2002;118:211-215
10. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000;14:163-176
11. Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-b secreted by endothelial cells by a novel mechanism. J Cell Biol 1993;122: 923-932
12. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 1998;93:1159-1170
13. Miller LA, Barnett NL, Sheppard D, Hyde DM. Expression of the b6 integrin subunit is associated with sites of neutrophil influx in lung epithelium. J Histochem Cytochem 2001;49:41-48
14. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, et al. The integrin avb6 binds and activates latent TGF-β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-328
15. Goodwin A, Jenkins G. Role of integrin-mediated TGFb activation in the pathogenesis of pulmonary fibrosis. Biochem Soc Trans 2009;37: 849-854
16. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix. J Cell Biol 2007;179:1311-1323
17. Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, MassaguéJ. The TGFb receptor activation process: an inhibitor-to substrate-binding switch. Mol Cell 2001;8:671-682
18. Shi Y, MassaguéJ. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700
19. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFb receptor. Cell 1998;95:779-791
20. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 2003;5:410-421
21. Xu L, MassaguéJ. Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol 2004;5:209-219
22. Inman GJ, Nicolás FJ, Hill CS. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor activity. Mol Cell 2002; 10:283-294
23. Bruce DL, Sapkota GP. Phosphatases in SMAD regulation. FEBS Lett 2012;586:1897-1905
24. Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, et al. PPM1A functions as a Smad phosphatase to terminate TGFb signaling. Cell 2006;125:915-928
25. Kretzschmar M, Doody J, Timokhina I, MassaguéJ. A mechanism of repression of TGFb/Smad signaling by oncogenic Ras. Genes Dev 1999;13:804-816
26. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. Cyclindependent kinases regulate the antiproliferative function of Smads. Nature 2004;430:226-231
27. Roelen BA, Cohen OS, Raychowdhury MK, Chadee DN, Zhang Y, Kyriakis JM, Alessandrini AA, Lin HY. Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-b-induced nuclear accumulation. Am J Physiol Cell Physiol 2003;285: C823-C830
28. Chen X, Wang H, Liao HJ, Hu W, Gewin L, Mernaugh G, Zhang S, Zhang ZY, Vega-Montoto L, Vanacore RM, et al. Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling. J Clin Invest 2014;124: 3295-3310
29. Aschner Y, Khalifah AP, Briones N, Yamashita C, Dolgonos L, Young SK, Campbell MN, Riches DW, Redente EF, Janssen WJ, et al. Protein tyrosine phosphatase a mediates profibrotic signaling in lung fibroblasts through TGF-β responsiveness. Am J Pathol 2014;184:1489-1502
30. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al. Targeted disruption of the mouse transforming growth factor-b1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699
31. Kulkarni AB, Karlsson S. Transforming growth factor-b1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 1993;143:3-9
32. Bartram U, Speer CP. The role of transforming growth factor b in lung development and disease. Chest 2004;125:754-765
33. Schmid P, Cox D, Bilbe G, Maier R, McMaster GK. Differential expression of TGFb1, b2 and b3 genes during mouse embryogenesis. Development 1991;111:117-130
34. Sanford LP, Ormsby I, Gittenberger-Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T. TGFb2 knockout mice have multiple developmental defects that are non-overlapping with other TGFb knockout phenotypes. Development 1997;124: 2659-2670
35. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995;11:415-421
36. Zhao J, Bu D, Lee M, Slavkin HC, Hall FL, Warburton D. Abrogation of transforming growth factor-b type II receptor stimulates embryonic mouse lung branching morphogenesis in culture. Dev Biol 1996;180: 242-257
37. Whitsett JA, Weaver TE, Lieberman MA, Clark JC, Daugherty C. Differential effects of epidermal growth factor and transforming growth factor-b on synthesis of Mr = 35,000 surfactant-associated protein in fetal lung. J Biol Chem 1987;262:7908-7913
38. Zhou L, Dey CR, Wert SE, Whitsett JA. Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-β1 chimeric gene. Dev Biol 1996;175:227-238
39. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 2009;9:447-453
40. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-b regulation of immune responses. Annu Rev Immunol 2006;24:99-146
41. Seoane J. Escaping from the TGFb anti-proliferative control. Carcinogenesis 2006;27:2148-2156
42. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH. TGF-β induces apoptosis through Smad-mediated expression of DAPkinase. Nat Cell Biol 2002;4:51-58
43. Schuster N, Krieglstein K. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res 2002;307:1-14
44. Stouffer GA, Owens GK. TGF-β promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest 1994;93:2048-2055
45. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001; 276:17058-17062
46. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB. Transforming growth factor type b induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84:5788-5792
47. Querfeld C, Eckes B, Huerkamp C, Krieg T, Sollberg S. Expression of TGF-β1,-b2 and-b3 in localized and systemic scleroderma. J Dermatol Sci 1999;21:13-22
48. Brown RL, Ormsby I, Doetschman TC, Greenhalgh DG. Wound healing in the transforming growth factor-b-deficient mouse. Wound Repair Regen 1995;3:25-36
49. Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB, et al. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 2002;160:1057-1068
50. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378:1949-1961
51. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824
52. Sisson TH, Mendez M, Choi K, Subbotina N, Courey A, Cunningham A, Dave A, Engelhardt JF, Liu X, White ES, et al. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med 2010;181:254-263
53. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011;208:1339-1350
54. Border WA, Noble NA. Transforming growth factor b in tissue fibrosis. N Engl J Med 1994;331:1286-1292
55. Li M, Krishnaveni MS, Li C, Zhou B, Xing Y, Banfalvi A, Li A, Lombardi V, Akbari O, Borok Z, et al. Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis. J Clin Invest 2011;121:277-287
56. Westergren-Thorsson G, Hernnäs J, Särnstrand B, Oldberg A, Heinega rd D, Malmström A. Altered expression of small proteoglycans, collagen, and transforming growth factor-b1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 1993;92:632-637
57. Bergeron A, Soler P, Kambouchner M, Loiseau P, Milleron B, Valeyre D, Hance AJ, Tazi A. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-β and IL-10. Eur Respir J 2003;22: 69-76
58. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor-b in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991;5: 155-162
59. Khalil N, Parekh TV, O'Connor R, Antman N, Kepron W, Yehaulaeshet T, Xu YD, Gold LI. Regulation of the effects of TGF-β1 by activation of latent TGF-β1 and differential expression of TGF-β receptors (TbR-I and TbR-II) in idiopathic pulmonary fibrosis. Thorax 2001;56: 907-915
60. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 2000;97: 1778-1783
61. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovectormediated gene transfer of active transforming growth factor-b1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997;100: 768-776
62. Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D, Murphy A, Chakravarty S, Dugar S, Higgins L, et al. Progressive transforming growth factor b1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med 2005; 171:889-898
63. Bonniaud P, Margetts PJ, Ask K, Flanders K, Gauldie J, Kolb M. TGF-β and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol 2005;175:5390-5395
64. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, Frank JA, Brumwell AN, Wheeler SE, Kreidberg JA, et al. Epithelial cell a3b1 integrin links b-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009; 119:213-224
65. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, Horowitz JC, Day RM, Thomas PE. Myofibroblast differentiation by transforming growth factor-b1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 2003;278: 12384-12389
66. Willis BC, Borok Z. TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293:L525-L534
67. Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J, Noble PW, Hogan BL. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA 2011;108: E1475-E1483
68. Larsson O, Diebold D, Fan D, Peterson M, Nho RS, Bitterman PB, Henke CA. Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS One 2008;3:e3220
69. Parker MW, Rossi D, Peterson M, Smith K, Sikström K, White ES, Connett JE, Henke CA, Larsson O, Bitterman PB. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest 2014;124:1622-1635
70. White ES, Lazar MH, Thannickal VJ. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 2003; 201:343-354
71. Xia H, Bodempudi V, Benyumov A, Hergert P, Tank D, Herrera J, Braziunas J, Larsson O, Parker M, Rossi D, et al. Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis. Am J Pathol 2014;184:1369-1383
72. Goumans MJ, Liu Z, ten Dijke P. TGF-β signaling in vascular biology and dysfunction. Cell Res 2009;19:116-127
73. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA, Loyd JE, Nichols WC, Trembath RC; International PPH Consortium. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat Genet 2000;26:81-84
74. Machado RD, Aldred MA, James V, Harrison RE, Patel B, Schwalbe EC, Gruenig E, Janssen B, Koehler R, Seeger W, et al. Mutations of the TGF-β type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 2006;27:121-132
75. West J, Fagan K, Steudel W, Fouty B, Lane K, Harral J, Hoedt-Miller M, Tada Y, Ozimek J, Tuder R, et al. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 2004;94:1109-1114
76. Graham BB, Chabon J, Gebreab L, Poole J, Debella E, Davis L, Tanaka T, Sanders L, Dropcho N, Bandeira A, et al. Transforming growth factor-b signaling promotes pulmonary hypertension caused by Schistosoma mansoni. Circulation 2013;128:1354-1364
77. Scherf W, Burdach S, Hansen G. Reduced expression of transforming growth factor b1 exacerbates pathology in an experimental asthma model. Eur J Immunol 2005;35:198-206
78. Hansen G, McIntire JJ, Yeung VP, Berry G, Thorbecke GJ, Chen L, DeKruyff RH, Umetsu DT. CD4(1) T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000;105:61-70
79. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-β antibody: effect on the Smad signaling pathway. J Immunol 2005;174:5774-5780
80. Gregory LG, Mathie SA, Walker SA, Pegorier S, Jones CP, Lloyd CM. Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med 2010;182:143-154
81. Aubert JD, Dalal BI, Bai TR, Roberts CR, Hayashi S, Hogg JC. Transforming growth factor b1 gene expression in human airways. Thorax 1994;49:225-232
82. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001;34:50s-59s
83. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, Okada Y, Yamasawa F, Nakahara K, Umeda A. Increased expression of transforming growth factor-b1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001;163: 1476-1483
84. Springer J, Scholz FR, Peiser C, Groneberg DA, Fischer A. SMADsignaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. Biol Chem 2004;385:649-653
85. Roberts AB. Medicine: smoke signals for lung disease. Nature 2003; 422:130-131
86. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D. Loss of integrin a(v)b6-mediated TGF-β activation causes MMP12-dependent emphysema. Nature 2003; 422:169-173
87. Marwick JA, Kirkham P, Gilmour PS, Donaldson K, MacNee W, Rahman I. Cigarette smoke-induced oxidative stress and TGF-β1 increase p21waf1/cip1 expression in alveolar epithelial cells. Ann N Y Acad Sci 2002;973:278-283
88. Rennard SI, Togo S, Holz O. Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema. Proc Am Thorac Soc 2006;3:703-708
89. Akhurst RJ, Hata A. Targeting the TGFb signalling pathway in disease. Nat Rev Drug Discov 2012;11:790-811
90. Fernandez IE, Eickelberg O. The impact of TGF-b on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc 2012;9:111-116
91. Rafii R, Juarez MM, Albertson TE, Chan AL. A review of current and novel therapies for idiopathic pulmonary fibrosis. J ThoracDis 2013;5:48-73
92. Higashiyama H, Yoshimoto D, Kaise T, Matsubara S, Fujiwara M, Kikkawa H, Asano S, Kinoshita M. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Exp Mol Pathol 2007;83:39-46
93. Koh RY, Lim CL, Uhal BD, Abdullah M, Vidyadaran S, Ho CC, Seow HF. Inhibition of transforming growth factor-b via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis. Mol Med Rep 2015; 11:3808-3813
94. Horan GS, Wood S, Ona V, Li DJ, Lukashev ME, Weinreb PH, Simon KJ, Hahm K, Allaire NE, Rinaldi NJ, et al. Partial inhibition of integrin a(v)b6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med 2008;177: 56-65
95. Rahaman SO, Grove LM, Paruchuri S, Southern BD, Abraham S, Niese KA, Scheraga RG, Ghosh S, Thodeti CK, Zhang DX, et al. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J Clin Invest 2014;124:5225-5238